- Home
- ECOR vs YXT Comparison
ECOR vs YXT Comparison
Compare ECOR & YXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- YXT
- Stock Information
- Founded
- ECOR 2005
- YXT 2011
- Country
- ECOR United States
- YXT China
- Employees
- ECOR N/A
- YXT N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- YXT
- Sector
- ECOR Health Care
- YXT
- Exchange
- ECOR Nasdaq
- YXT NYSE
- Market Cap
- ECOR 111.3M
- YXT 129.2M
- IPO Year
- ECOR 2018
- YXT 2024
- Fundamental
- Price
- ECOR $15.90
- YXT $1.98
- Analyst Decision
- ECOR Strong Buy
- YXT
- Analyst Count
- ECOR 1
- YXT 0
- Target Price
- ECOR $25.00
- YXT N/A
- AVG Volume (30 Days)
- ECOR 144.8K
- YXT 94.4K
- Earning Date
- ECOR 03-12-2025
- YXT 02-21-2025
- Dividend Yield
- ECOR N/A
- YXT N/A
- EPS Growth
- ECOR N/A
- YXT N/A
- EPS
- ECOR N/A
- YXT 3.06
- Revenue
- ECOR $23,327,000.00
- YXT $48,030,651.00
- Revenue This Year
- ECOR $59.81
- YXT N/A
- Revenue Next Year
- ECOR $38.49
- YXT N/A
- P/E Ratio
- ECOR N/A
- YXT $0.65
- Revenue Growth
- ECOR 74.10
- YXT N/A
- 52 Week Low
- ECOR $5.32
- YXT $1.82
- 52 Week High
- ECOR $18.67
- YXT $11.00
- Technical
- Relative Strength Index (RSI)
- ECOR 53.73
- YXT N/A
- Support Level
- ECOR $15.50
- YXT N/A
- Resistance Level
- ECOR $16.12
- YXT N/A
- Average True Range (ATR)
- ECOR 1.20
- YXT 0.00
- MACD
- ECOR -0.31
- YXT 0.00
- Stochastic Oscillator
- ECOR 40.17
- YXT 0.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS
Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.